(Q51832493)

13 April 2018

title

Association of plasma resistin levels with coronary heart disease in women. (English)

1 reference

13 April 2018

1 reference

coronary artery disease

1 reference

1

1 reference

13 April 2018

Heiner Boeing

6

object named as

Heiner Boeing

1 reference

13 April 2018

3

Jürgen Kratzsch

1 reference

13 April 2018

author name string

Christoph M Bamberger

2

1 reference

13 April 2018

Birgit-Christiane Zyriax

4

1 reference

13 April 2018

Petra Algenstaedt

5

1 reference

13 April 2018

Eberhard Windler

7

1 reference

13 April 2018

publication date

1 October 2005

1 reference

13 April 2018

published in

Obesity

1 reference

13 April 2018

volume

13

1 reference

13 April 2018

issue

10

1 reference

13 April 2018

page(s)

1764-1771

1 reference

13 April 2018

The hormone resistin links obesity to diabetes

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

A family of tissue-specific resistin-like molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Effect of metformin on adipose tissue resistin expression in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Resistin gene expression in human adipocytes is not related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Serum Resistin (FIZZ3) Protein Is Increased in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Correlation between serum resistin level and adiposity in obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Decline in the risk of myocardial infarction among women who stop smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

The primary prevention of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

The effect of differences in measurement procedure on the comparability of blood pressure estimates in multi-centre studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Inflammatory bio-markers and cardiovascular risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Expression of resistin in the adipose tissue is modulated by various factors including peroxisome proliferator-activated receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Serum resistin (FIZZ3) protein is increased in obese humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

Do resistin and resistin-like molecules also link obesity to inflammatory diseases?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.215

31 March 2020

Identifiers

DOI

10.1038/OBY.2005.215

1 reference

13 April 2018

1 reference

13 April 2018